Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
agitation
amyloid angiopathy, cerebral
amyloid angiopathy, cerebral, incidence
autoregulation, cerebral
brain purpura
brainstem, infarction of
cerebral edema
cerebrovascular accident
coma
confusion
dementia
disseminated intravascular coagulation(DIC)
drowsiness
fibrinoid necrosis
fundus, abnormality of
head injury
headache
hypertensive encephalopathy
intracerebral hemorrhage
intracerebral hemorrhage, lobar
level of consciousness, decreased
microaneurysm, cerebral
microglial nodules
microinfarcts
neuropathology
neuropathology, brain
papilledema
review article
seizure
trauma
uremia
vasospasm, cerebral
vision, blurred
Showing articles 300 to 350 of 927 << Previous Next >>

Diagnosis and Management of Patients at Risk of or with Metastatic Spinal Cord Compression: Summary of NICE Guidance
BMJ 337:1349-1351, White,B.D.,et al, 2008

Patterns of Care in Elderly Glioblastoma Patients
Ann Neurol 64:628-632,597, Iwamoto,F.M.,et al, 2008

Takotsubo Cardiomyopathy in Acute Ischemic Stroke
Ann Neurol 64:547-554, Yoshimura,S.,et al, 2008

Natalizumab Use in Pediatric Multiple Sclerosis
Arch Neurol 65:1655-1658, Huppke,P.,et al, 2008

Response of Anti-NMDA Receptor Encephalitis Without Tumor to Immunotherapy Including Rituximab
Neurol 71:1921-1923, Ishiura,H.,et al, 2008

Treatment of Neuromyelitis Optica with Rituximab; Retrospective Analysis of 25 Patients
Arch Neurol 65:1443-1448, Jacob,A.,et al, 2008

A Herpes Simplex Virus-1 Fatal Encephalitis Following Chemo-Radiotherapy, Steroids and Prophylactic Cranial Irradiation in a Small Cell Lung Cancer Patient
Lung Cancer 57:243-246, Silvano,G.,et al., 2007

Radiotherapy for Glioblastoma in the Elderly
NEJM 356:1527-1535, Keime-Guibert,F.,et al, 2007

Natalizumab Reduces Visual Loss in Patients with Relapsing Multiple Sclerosis
Neurol 68:1299-1302, Balcer,L.J.,et al, 2007

Quantifying the Risks and Benefits of Natalizumab in Relapsing Multiple Sclerosis
Neurol 68:1524-1528, Dorsey,E.R.,et al, 2007

MRI Outcomes in a Placebo-Controlled Trial of Natalizumab in Relapsing MS
Neurol 68:1390-1401, Miller,D.H.,et al, 2007

Refractory Neurosarcoidosis Responsive to Infliximab
Pract Neurol 7:112-115, Kobylecki,C. &Shaunak,S., 2007

Readmission and Death After Hospitalization for Acute Ischemic Stroke. 5-Year Follow-Up in the Medicare Population
Stroke 38:1899-1904, Bravata,D.M.,et al, 2007

Pattern of Cortical Changes in Sporadic Creutzfeldt-Jakob Disease
AJNR 28:1114-1118, Tschampa,H.J.,et al, 2007

Natalizumab for Multiple Sclerosis
NEJM 356:2622-2629, Ransohoff,R.M., 2007

Natalizumab (Tysabri) Treatment for Relapsing Multiple Sclerosis
The Neurologist 13:182-187, Johnson,K.P., 2007

Progressive Multifocal Leukoencephalopathy After Rituximab in a Case of Non-Hodgkin Lymphoma
Neurol 69:704-706, Kranick,S.M.,et al, 2007

Prophylactic Cranial Irradiation in Extensive Small-Cell Lung Cancer
NEJM 356:664-672, Slotman,B.,et al, 2007

Outcome in Adult Low-Grade Glioma: The Impact of Prognostic Factors and Treatment
Neurol 69:1366-1373, Schiff,D.,et al, 2007

Limbic Encephalitis and Variants: Classification, Diagnosis and Treatment
Neurologist 13:261-271, Tuzun,E. &Dalmau,J., 2007

Clinicopath Conf., Left Atrial Myxoma with Systemic Embolization
NEJM 357:1137-1145, Case 28-2007, 2007

Salvage Whole Brain Radiotherapy for Recurrent or Refractory Primary CNS Lymphoma
Neurol 69:1178-1182, Hottinger,A.F.,et al, 2007

Daclizumab Phase II Trial in Relapsing and Remitting Multiple Sclerosis
Neurol 69:785-789, Rose,J.W.,et al, 2007

Health-Related Quality of Life in Multiple Sclerosis: Effects of Natalizumab
Ann Neurol 62:335-346, Rudick,R.A.,et al, 2007

Leukoencephalopathy during administration of etanercept for refractory rheumatoid arthritis
Mod Rheumatol 17-72-74, Yamamoto, M.,et al, 2007

Encephalopathy, Stroke, and Myocardial Infarction With DMSO Use in Stem Cell Transplantation
Neurol 68:859-861, Chen-Plotkin,A.S.,et al, 2007

Transient Postictal MRI Changes in Patients with Brain Tumors may Mimic Disease Progression
Surg Neurol 67:246-250, Finn, M.A.,et al, 2007

Intracranial Hemorrhage in Patients Treated with Bevacizumab and Low-Molecular Weight Heparin
Clin Adv Hematol Oncol 5:375-379, Nguyen, T.D.,et al, 2007

Rapidly Fatal Acanthamoeba Encephalitis and Treatment of Cryoglobulinemia
Emerg Infect Dis 13:469-471, Meersseman, W.,et al, 2007

Sensorineural Hearing Loss After Radiotherapy and Chemoradiotherapy: A Single, Blinded, Randomized Study
J Clin Oncol 24:1904-1909, Low, W.K.,et al, 2006

Diffuse Pontine Glioma
UpToDate, April, Kieran,M.W., 2006

Focal Brainstem Gliomas
UpToDate, April, Kieran,M.W., 2006

Early Coronary Revascularization Diminishes the Risk of Ischemic Stroke with Acute Myocardial Infarction
Stroke 37:2546-2551, vanDeGraaff,E.,et al, 2006

Myocardial Injury in patients with Intracerebral Hemorrhage Treated with Recombinant Factor VIIa
Neurol 67:1053-1055, Sugg,R.M.,et al, 2006

Unrecognized Myocardial Infarction and the Risk of Stroke: The Rotterdam Study
Neurol 67:1635-1639, Ikram,M.A.,et al, 2006

Infusion-Related Hypersensitivity Reactions During Natalizumab Treatment
Neurol 67:1717-1718, Phillips,J.T.,et al, 2006

Retinopathy in Survivors of Primary Central Nervous System Lymphoma
Neurol 67:2060-2062, Grimm,S.A.,et al, 2006

Acromegaly
NEJM 355:2558-2573, Melmed,S., 2006

Voltage-Gated Potassium Channel Antibody-Associated Encephalitis with Basal Ganglia Lesions
Neurol 66:1780-1781, Hiraga,A., et al, 2006

Cortical Laminar Necrosis Related to Prolonged Focal Status Epilepticus
JNNP 77:104-106, Donaire,A.,et al, 2006

Thromboembolic Adverse Events After Use of Recombinant Human Coagulation Factor VIIa
JAMA 295:293-298, OConnell,K.A.,et al, 2006

Myocardial Injury and Long-Term Mortality Following Moderate to Severe Carbon Monoxide Poisoning
JAMA 295:398-402, Henry,C.R.,et al, 2006

CT and MR Imaging Findings in Methanol Intoxication
AJNR 27:452-454, Blanco,M.,et al, 2006

Left Insular Stroke is Associated with Adverse Cardiac Outcome
Neurol 66:477-483, Laowattana,S.,et al, 2006

Natalizumab Plus Interferon Beta -1a for Relapsing Multiple Sclerosis
NEJM 354:911-923,965, Rudick,R.A.,et al, 2006

A Randomized, Placebo-Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis
NEJM 354:899-910,965, Polman,C.H.,et al, 2006

Evaluation of Patients Treated with Natalizumab for Progressive Multifocal Leukoencephalopathy
NEJM 354:924-933,965, Yousry,T.A.,et al, 2006

Clinicopath Conf, Diffuse Large B-Cell Lymphoma, EBV-Positive, with Immunosuppression
NEJM 354:1178-1184, Case 8-2006, 2006

Electrocardiogram in Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy Patients Without Any Clinical Evidence of Coronary Artery Disease
Stroke 37:1100-1102, Cumurciuc,R.,et al, 2006

ADHD Drugs and Cardiovascular Risk
NEJM 354:1445-1448, Nissen,S.E., 2006



Showing articles 300 to 350 of 927 << Previous Next >>